Medicine and Dentistry
Meta-Analysis
100%
Percutaneous Aortic Valve Replacement
66%
Percutaneous Coronary Intervention
56%
Myocardial Infarction
40%
Heart Surgery
35%
Odds Ratio
34%
Cardiovascular System
33%
ST Segment Elevation Myocardial Infarction
32%
Coronary Artery Disease
31%
Acidosis
31%
Revascularization
30%
Randomized Controlled Trial
29%
Drug-Eluting Stent
28%
Acute Heart Infarction
26%
Heart Failure
26%
Chronic Total Occlusion
22%
Mortality Rate
21%
Aortic Stenosis
20%
Systematic Review
20%
Exercise
19%
Thrombosis
18%
Apoplexy
17%
COVID-19
17%
Pulmonary Embolism
17%
Acute Coronary Syndrome
17%
Cardiac Resynchronization Therapy
17%
Primary Percutaneous Coronary Intervention
16%
Medicare
16%
Biological Marker
15%
All Cause Mortality
15%
Long Term Survival
15%
Stent Thrombosis
15%
Randomized Clinical Trial
14%
Diabetes Mellitus
14%
Health Care Cost
14%
Aortic Valve
14%
Heart Stress
13%
Patient with Diabetes
13%
ST Elevation
12%
Drug Therapy
12%
Angiography
12%
Adverse Event
12%
Cardiopulmonary Bypass
11%
Radiation Exposure
11%
Restenosis
11%
Cardiovascular Disease
11%
Clinical Trial
11%
Cardiac Catheterization
11%
Disease
11%
Combination Therapy
11%
Keyphrases
Meta-analysis
48%
Transcatheter Aortic Valve Replacement
35%
Confidence Interval
34%
ST-elevation Myocardial Infarction (STEMI)
27%
Randomized Trial
19%
Drug-eluting Stent
19%
Percutaneous Coronary Intervention
18%
Myocardial Infarction
17%
Odds Ratio
16%
Clinical Outcomes
16%
Randomized Clinical Trial
16%
Myocardial Acidosis
15%
Temporal Trends
14%
Chronic Total Occlusion
13%
Stent Thrombosis
13%
All-cause Mortality
13%
Cardiac Stress
13%
Transcatheter Aortic Valve Implantation
13%
Self-expanding Valve
13%
Risk Ratio
12%
Primary Percutaneous Coronary Intervention
12%
Balloon-expandable Valve
12%
Cardiac Surgery
12%
Randomized Controlled Trial
10%
Bare Metal Stent
10%
Systematic Meta-analysis
9%
Coronary Artery Disease
9%
Acute Kidney Injury
9%
Statins
9%
Aortic Stenosis
9%
Chronic Coronary Disease
8%
Updated Meta-analysis
8%
Transvalvular Gradient
8%
Acute Myocardial Infarction
8%
Comprehensive Meta-analysis
8%
Cardiac Damage
8%
Acute Coronary Syndrome
8%
Secondary Prevention
8%
Primary Angioplasty
8%
Spontaneous Coronary Artery Dissection
8%
Aspiration Thrombectomy
8%
Low-middle Income Countries
8%
Hospitalization
8%
Restenosis
7%
Cardiopulmonary Bypass
7%
In-hospital Mortality
7%
Readmission Rates
7%
Patient Management
7%
Aortic Cross-clamping
6%
Mortality Rate
6%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Infarction
45%
Coronary Artery Disease
30%
Heart Failure
27%
ST Segment Elevation Myocardial Infarction
27%
Disease
22%
All Cause Mortality
20%
Randomized Controlled Trial
19%
Acute Heart Infarction
18%
Thrombosis
18%
Acute Coronary Syndrome
18%
Randomized Clinical Trial
17%
Fibrinolytic Agent
17%
Stent Thrombosis
16%
Brain Hemorrhage
14%
Aortic Stenosis
14%
Statin (Protein)
14%
Cardiovascular Disease
13%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
12%
Bleeding
11%
Diabetes Mellitus
11%
Ticagrelor
11%
Restenosis
10%
Biological Marker
10%
Non Insulin Dependent Diabetes Mellitus
9%
Non ST Segment Elevation Myocardial Infarction
8%
Infarction
8%
Chronic Total Occlusion
8%
Heart Stress
8%
Lung Embolism
8%
Heart Failure with Preserved Ejection Fraction
8%
Unstable Angina Pectoris
8%
Acetylsalicylic Acid
8%
Adverse Event
8%
Paclitaxel
8%
Mortality Rate
8%
Antiplatelet
8%
Coronavirinae
7%
Symptom
7%
Ischemia
7%
Clopidogrel
7%
Pandemic
6%
Antithrombocytic Agent
6%
Hospital Mortality
6%
Prevalence
6%
Antihypertensive Agent
5%
Placebo
5%
Prematurity
5%
Major Adverse Cardiac Event
5%
Cardiomyopathy
5%
Anticoagulant Agent
5%
